Nothing Special   »   [go: up one dir, main page]

Tatarkiewicz et al., 1999 - Google Patents

REVERSAL OF HYPERGLYCEMIA IN MICE AFTER SUBCUTANEOUS TRANSPLANTATION OF MACROENCAPSULATED ISLETS1

Tatarkiewicz et al., 1999

Document ID
13864273634222758737
Author
Tatarkiewicz K
Hollister-Lock J
Quickel R
Colton C
Bonner-Weir S
Weir G
Publication year
Publication venue
Transplantation

External Links

Snippet

Background. Macroencapsulated islets can reverse hyperglycemia in diabetic animals when transplanted ip or into the fat pad. The sc space is an attractive site for such transplantation because macrocapsules can be implanted with local anesthesia and be easily removed or …
Continue reading at journals.lww.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/39—Pancreas; Islets of Langerhans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Similar Documents

Publication Publication Date Title
Tatarkiewicz et al. REVERSAL OF HYPERGLYCEMIA IN MICE AFTER SUBCUTANEOUS TRANSPLANTATION OF MACROENCAPSULATED ISLETS1
Pileggi et al. Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device
Juang et al. Outcome of subcutaneous islet transplantation improved by polymer device1
Korsgren et al. Current status of clinical islet transplantation
Suzuki et al. FUNCTION AND SURVIVAL OF MACROENCAPSULATED SYNGENEIC ISLETS TRANSPLANTED INTO STREPTOZOCIN-DIABETIC MICE1
Anazawa et al. Current state and future evolution of pancreatic islet transplantation
Pepper et al. Diabetes is reversed in a murine model by marginal mass syngeneic islet transplantation using a subcutaneous cell pouch device
Pepper et al. A prevascularized subcutaneous device-less site for islet and cellular transplantation
Maki et al. Treatment of diabetes by xenogeneic islets without immunosuppression: use of a vascularized bioartificial pancreas
Balamurugan et al. Bioartificial pancreas transplantation at prevascularized intermuscular space: effect of angiogenesis induction on islet survival
Yang et al. Long-term efficacy and biocompatibility of encapsulated islet transplantation with chitosan-coated alginate capsules in mice and canine models of diabetes
Trivedi et al. Islets in alginate macrobeads reverse diabetes despite minimal acute insulin secretory responses1
MAKI et al. Successful treatment of diabetes with the biohybrid artificial pancreas in dogs
Wang et al. Successful allotransplantation of encapsulated islets in pancreatectomized canines for diabetic management without the use of immunosuppression
Noguchi et al. Iodixanol-controlled density gradient during islet purification improves recovery rate in human islet isolation
Pepper et al. Harnessing the foreign body reaction in marginal mass device-less subcutaneous islet transplantation in mice
Wang et al. Subcutaneous transplantation of macroencapsulated porcine pancreatic endocrine cells normalizes hyperglycemia in diabetic mice1
Sandler et al. ASSESSMENT OF INSULIN SECRETION IN VITRO FROM MICROENCAPSULATED FETAL PORCINE ISLET-LIKE CELL CLUSTERS AND RAT, MOUSE, AND HUMAN PANCREATIC ISLETS1
JP2009533340A (en) Multi-membrane immunoisolation system for cell grafts
Kin et al. Xenotransplantation of pig islets in diabetic dogs with use of a microcapsule composed of agarose and polystyrene sulfonic acid mixed gel
Yang et al. LONG-TERM FUNCTION OF FISH ISLET XENOGRAFTS IN MICE BY ALGINATE ENCAPSULATION1
Uyama et al. Hepatocyte transplantation using biodegradable matrices in ascorbic acid-deficient rats: Comparison with heterotopically transplanted liver grafts1
Makhlouf et al. Importance of hyperglycemia on the primary function of allogeneic islet transplants1
Kuwabara et al. Long-term functioning of allogeneic islets in subcutaneous tissue pretreated with a novel cyclic peptide without immunosuppressive medication
Patikova et al. The optimal maturation of subcutaneous pouch can improve pancreatic islets engraftment in rat model